Investigational Site Number : 1560012

Kunming 650000

0 studies enrolling now · 1 studies all time

What they study most

Hemophilia

Studies at this site

• Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX — Running, not enrolling